Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1868, Issue 1, Pages 157-166Publisher
ELSEVIER
DOI: 10.1016/j.bbcan.2017.03.007
Keywords
Cancer biomarkers; Exosomes; Extracellular vesicles; Glycoconjugates; Glycoproteins; Glycosylation
Categories
Funding
- Euronanomed 2 ERA-NET, project GlioEx
- Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [ENMed/0001/2013]
- FCT/Ministerio da Educacao e Ciencia [iNOVA4Health-UID/Multi/04462/2013]
- Fundação para a Ciência e a Tecnologia [ENMed/0001/2013] Funding Source: FCT
Ask authors/readers for more resources
Extracellular vesicles (EVs) are released by virtually all cells, carry cellular molecules to the extracellular environment, and may interact with other cells. They are found in body fluids, therefore, constituting useful target sources for the identification of disease biomarkers, for example, in cancer. EVs originate from the plasma membrane or from multivesicular endosomes. They have the same topology as the plasma membrane and are rich in glycoconjugates, displaying specific glycosignatures. Surface glycoconjugates play important roles in EVs biogenesis and in their interaction with other cells. Changes in glycosylation constitute a hallmark of different types of cancer, therefore, the study of glycoconjugates and glycosignatures of EVs appear as promising candidates to identify novel cancer biomarkers and to increase the specificity and sensitivity of the existing clinical biomarkers, many of which are glycosylated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available